Navigating the new era of clinical trial transparency This issue of Medical Writing comes at a time when the summer holidays are behind us. Here’s hoping it has been a relaxing and rejuvenating time for all. As we get back to our day-to-day work, our fellow EMWA colleagues bring us an expert insight into the latest requirements in clinical trial transparency and disclosure. As medical writers, this has been on our agenda for many years now, but as we look to the future, transparency in clinical research is emerging as more than just a regulatory requirement – it is a cornerstone of public trust and ethical responsibility.   Medical Writing. 2024;33(3):8. https://doi.org/10.56012/ofqn1420